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Miniabstract 26 
128 patients undergoing elective laparoscopic colorectal resections were randomized 27 
to epidural (EDA) versus patient-controlled opioid-based analgesia (PCA). Medical 28 
recovery and high dependency stay were longer in EDA patients but hospital stay 29 
was similar. 30% of EDA patients needed transitory vasopressor treatment. There 30 
was no difference in postoperative pain scores.31 
 1 
Abstract 32 
Objective: To compare epidural analgesia (EDA) to patient-controlled opioid-based 33 
analgesia (PCA) in patients undergoing laparoscopic colorectal surgery. 34 
Summary background data: EDA is mainstay of multimodal pain management 35 
within enhanced recovery pathways (ERAS®). For laparoscopic colorectal resections, 36 
the benefit of epidurals remains debated. Some consider EDA as useful, while others 37 
perceive epidurals as unnecessary or even deleterious. 38 
Methods: A total of 128 patients undergoing elective laparoscopic colorectal 39 
resections were enrolled in a randomized clinical trial comparing EDA versus PCA. 40 
Primary endpoint was medical recovery. Overall complications, hospital stay, 41 
perioperative vasopressor requirements, and postoperative pain scores were 42 
secondary outcome measures. Analysis was performed according to the intention-to-43 
treat principle. 44 
Results: Final analysis included 65 EDA patients and 57 PCA patients. Both groups 45 
were similar regarding baseline characteristics. Medical recovery required a median 46 
of 5 days (IQR 3;7.5) in patients with EDA and 4 days (IQR 3;6) in the PCA group 47 
(P= 0.082). PCA patients had significantly less overall complications (19 (33%) vs. 35 48 
(54%); P= 0.029) but a similar hospital stay (5 days (IQR 4;8) vs. 7 days (IQR 49 
4.5;12); P= 0.434). Significantly more EDA patients needed vasopressor treatment 50 
perioperatively (90 vs. 74%, P= 0.018), the day of surgery (27 vs. 4%, P< 0.001), and 51 
on postoperative day 1 (29 vs. 4%, P< 0.001), while no difference in postoperative 52 
pain scores was noted. 53 
Conclusions: Epidurals appear to slow down recovery after laparoscopic colorectal 54 
resections without adding obvious benefits. EDA can therefore not be recommended 55 
as part of ERAS® pathways in laparoscopic colorectal surgery. 56 
 2 
Registration number: NCT00508300 (http://www.clinicaltrials.gov). 57 
 3 
Introduction 58 
  Enhanced recovery (ERAS®) pathways have proven to reduce significantly 59 
complications, postoperative length of stay and costs after colorectal surgery1-3. The 60 
multimodal treatment bundle contains about 20 individual items to attenuate surgical 61 
stress response and thus to improve recovery4, 5. High compliance with the 62 
recommended pathway was strongly correlated with favorable clinical outcomes6. 63 
Previous randomized trials identified optimized fluid management, minimal invasive 64 
surgery, and epidural analgesia (EDA) as key items of ERAS® concepts2, 7. 65 
  The benefit of EDA however remains controversial especially when combined 66 
with minimal invasive surgery8-12. Expert laparoscopic centers have reported 67 
excellent outcomes without use of EDA13-16. Moreover, a recent prospective study 68 
suggested even slower recovery if EDA was employed after laparoscopic 69 
colectomy16. Furthermore, novel strategies for pain management rendered promising 70 
results17, 18. This obvious mismatch of recommendations, available evidence and 71 
current practice can only be reconciled with more prospective data. 72 
 73 
  The aim of this prospective randomized trial was therefore to test the 74 
hypothesis that EDA improves recovery after laparoscopic colorectal resections when 75 
compared with patient-controlled opioid-based analgesia (PCA). 76 
77 
 4 
Methods 78 
Study design 79 
A single center, prospective parallel-group superiority study with balanced 80 
randomization (1:1) was performed to compare the clinical effects of EDA vs. 81 
morphine-based PCA (EvA trial) in patients undergoing laparoscopic colorectal 82 
resections. 83 
The institutional ethics committee approved the study (# 166/07), and all 84 
patients provided written informed consent before enrollment. The trial was 85 
registered under clinicaltrial.gov (trial # NCT00508300) before patient recruitment 86 
was started. 87 
 88 
Patients and setting 89 
All patients undergoing elective laparoscopic colorectal surgery at the 90 
University Hospital of Lausanne (CHUV), a tertiary referral center in Switzerland, 91 
were assessed for eligibility. Exclusion criteria included age below 18 years, inability 92 
to provide informed consent, and medical contraindication for EDA according to 93 
institutional guidelines19, 20. 94 
 95 
Enrolment and randomization 96 
Patients were assessed for eligibility at outpatient consultation by the 97 
operating surgeon once the indication for surgery was established. Patients received 98 
oral and written information on the study before written consent was obtained. 99 
Patients were randomly assigned by a dedicated study nurse using an online 100 
randomization program (Randomizer, Institute for Medical Informatics, Statistics and 101 
Documentation, Medical University of Graz, Austria; URL: http://www.randomizer.at). 102 
 5 
For medical and logistic reasons, blinding was not performed, as it appeared neither 103 
feasible nor realistic for this present study. 104 
 105 
Interventions, anesthesia and pain strategy 106 
Patients were randomized the day prior to surgery to allow for appropriate 107 
information on the anesthesia technique.  108 
In the EDA group, epidural catheter was inserted at thoracic level (Th 8-10) 109 
before induction of anesthesia. A bolus of 5ml of bupivacaine 0.5% was started as 110 
soon as the epidural catheter was in place, and a continuous perfusion of 111 
bupivacaine 0.5% at 5 ml/h was initiated until the end of surgical procedure. 112 
In both groups, induction of anesthesia was performed with propofol 1-2 113 
mg/kg, fentanyl 2-3 µg/kg and cisatracurium (0.15-0.2 mg/kg) for muscle paralysis. 114 
After tracheal intubation, maintenance of anesthesia was performed with sevoflurane 115 
in a mixed oxygen/air fresh gaz, and cisatracurium as needed. Analgesia was 116 
assured by the bupivacaine solution in the epidural group and by fentanyl as needed 117 
in the PCA group.  118 
At the end of surgery, a solution of bupivacaine 0.1%, fentanyl 2 µg/ml and 119 
adrenaline 2 µg/ml was initiated in the epidural group at a rate of 6-10 ml/h (target: 120 
VAS<4) with bolus of 3 ml of the solution allowed every 40 minutes (Patient 121 
Controlled Epidural Analgesia)20. In the PCA group, iv PCA with morphine 1 mg/ml, 122 
with bolus of 1 ml at every 5 minutes and a locked of 40 mg/4 hours was inserted. 123 
All patients received paracetamol 4x1g/day and metamizole 4x500mg/day as 124 
baseline analgesic treatment unless contraindicated. Pain assessment was done 125 
twice daily at rest and on mobilization or coughing by a dedicated institutional 126 
analgesia team. Failure of either technique (VAS persistently >3) was recorded by 127 
the analgesia team and rescue pain relief was administered if necessary (morphine 128 
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subcutaneously 0.1 mg/kg maximum 6x/d or buprenorphine sublingual 0.2-0.4 mg 129 
maximum 3x/d). Both interventions were planned to be discontinued on postoperative 130 
day (POD) 2 following international recommendations21, 22. EDA and PCA could be 131 
continued if the analgesia team judged that a prolonged application was beneficial for 132 
the patient. The day of discontinuation was documented. 133 
During anesthesia and for the following postoperative days, maintenance of 134 
blood pressure >60mmHg or diuresis > 0.5 ml/kg/h was aimed for, first by 135 
administration of volume, Ringer-lactate 500 ml or 500 ml colloids (Voluven®). 136 
Noradrenaline at a dose of 0-10µg/h was used as vasopressor if blood pressure was 137 
not corrected by volume administration. Substitution of blood products was done if 138 
hematocrit < 25%, or at the discretion of the anesthetist in charge of the procedure. 139 
 140 
Perioperative care pathway 141 
 Enhanced recovery was introduced in our institution in 2006 using a protocol 142 
which was adapted after a first randomized trial from our group2. After the recruitment 143 
for the present EvA trial had started, it was decided in June 2011 to adapt the 144 
pathway according to the in meantime published ERAS® recommendations21 and to 145 
reinforce application of the pathway by a structured implementation program. Our 146 
ERAS® pathway complies with the most recent ERAS® guidelines4, 5 and was 147 
reported along with clinical and economic outcomes in 20133. 148 
 149 
Outcomes/study endpoints 150 
Outcomes were analyzed according to the intention-to-treat principle. Medical 151 
recovery was chosen as primary endpoint and was defined as meeting all of the 152 
three following criteria: (I) sufficient pain control by oral analgesics, (II) fully mobilized 153 
or at least comparable with preoperative status, and (III) tolerance of oral food which 154 
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was defined as ≥2/3 of normal meal (hospital portion)23. Medical recovery was 155 
considered as more specific outcome parameter than hospital stay, as social and 156 
logistic factors are not interfering24, 25. Secondary endpoints were postoperative 157 
hospital stay and length of stay in the high dependency unit. Postoperative 30-day 158 
morbidity was graded by use of the Dindo-Clavien classification26; major 159 
complications were defined as complication grade 3-5. Use of perioperative 160 
vasopressor treatment was documented for every patient until 4 days after surgery. 161 
Pain relief was assessed by use of a visual analogue scale (VAS: 0-10) with a 162 
baseline value the day before surgery; routine evaluation twice daily started the 163 
evening of the surgery day and was continued until POD 4. 164 
Demographic information (age, gender, body mass index, Charlson co-165 
morbidity index 27, and the American Society of Anesthesiologists (ASA) grade) as 166 
well as pertinent surgical information (indication, type of surgery, conversion rate, 167 
operation time, estimated blood loss) were all predefined. Outcomes were assessed 168 
by dedicated study nurses who entered data in a specifically designed computerized 169 
database. 170 
 171 
Subgroup analyses 172 
EDA group happened to have more overall and major complications that could 173 
not be attributed to the allocated analgesic interventions as suggested by previous 174 
studies1, 8. Major complications prolong medical recovery and hospital stay and entail 175 
thus an obvious bias in favor of the PCA group28. For this reason, a post hoc 176 
subgroup analysis excluding patients with major complications was additionally 177 
performed. 178 
Primary and secondary endpoints depend not only on the allocated analgesic 179 
intervention but also heavily on the global perioperative care strategy3, 6, 15, 25. With 180 
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the adaptation of the institutional enhanced recovery pathway to ERAS® guidelines 181 
during the study period, it was decided to analyze patients within the full ERAS® 182 
pathway separately as a subgroup. 183 
The main purpose of these two additional analyses was to assess for potential 184 
bias of those influencing factors in order to filter the intrinsic effect of EDA vs. PCA on 185 
medical recovery and length of stay. 186 
 187 
Statistics 188 
Sample size computation based on a mean reduction of medical recovery time 189 
of 1.5±2.25 days by use of EDA2, 8, 29. Adopting a power of 90%, a two-sided type I 190 
error (α) of 0.05 and an anticipated drop-out rate of 10%, the calculated sample size 191 
was 64 patients per group. 192 
Descriptive statistics were reported as absolute or relative frequencies for 193 
categorical variables and as median (range or interquartile range - IQR) or mean (± 194 
SD) for continuous variables as appropriate. Fisher’s exact test was employed to 195 
analyze categorical variables. Student’s t test and Mann-Whitney U test were used to 196 
compare normal and non-normal continuous variables, respectively. 197 
Data was analyzed by use of the Statistical Package for the Social Sciences 198 
(SPSS 21.0, Inc., Chicago, IL USA) and Prism 6.03 (GraphPad® Software, Inc. 2236 199 
Avenida de la Playa La Jolla, CA 92037 USA). 200 
The trial was conducted and the results are presented according to the 201 
CONSORT guidelines 30.202 
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Results 203 
Between February 10th 2010 and October 15th 2013, 266 consecutive patients 204 
were assessed for eligibility. 138 patients did not meet the inclusion criteria or 205 
refused to participate. The remaining 128 patients were randomized to receive either 206 
EDA (n=67) or PCA (n=61) as allocated treatment. Two EDA patients and four PCA 207 
patients dropped out after randomization and no patient was lost to follow-up. Final 208 
analysis compared therefore 65 EDA patients with 57 patients with PCA (Figure 1). 209 
 Both comparative groups were similar in terms of pertinent demographic 210 
parameters and surgical aspects as displayed in Table 1. 211 
 212 
Technical success rates and duration of EDA and PCA treatment 213 
 Eight EDA were judged non-functioning and removed consistently on POD 0 214 
(n=2) and POD 1 (n=6). Overall failure rate was thus 12%. EDA and PCA were 215 
discontinued according to the study protocol on POD 2 in 47 (72%) and 55 (96%) of 216 
patients, respectively (P=0.005). EDA was left in place in twelve of the remaining 18 217 
patients until POD 3 and in 3 patients until POD 4. EDA was removed on POD 5, 6, 218 
and 7 in one patient each. Treatment time was therefore significant longer in the EDA 219 
group (2.33±1.17 days vs. 1.65±0.66 days, P<0.001). The urinary catheter was 220 
removed on POD1 according to the protocol in 44 EDA patients (68%) and 28 221 
patients (49%) of the PCA group (P=0.044). Urinary retention requiring reinsertion of 222 
the Foley catheter occurred in 11 (17%) EDA and 7 (12%) PCA patients, respectively 223 
(P=0.611). 224 
 225 
Medical recovery, complications and length of stay 226 
Medical recovery required a median of 5 (IQR 3;7.5) days in the EDA group 227 
and 4 (IQR 3;6) days in patients with PCA (P=0.082). The 3 mandatory preconditions 228 
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for medical recovery were analyzed separately as well. Full mobilization and oral pain 229 
control were achieved in both groups after a median of one and two days, 230 
respectively. The last requirement met was sufficient oral intake after a median of 4 231 
(IQR 2;6) days in EDA patients vs. 3 (IQR 2;4) days in the PCA group (P=0.114). 232 
Median stay at the high dependency unit was 1 (IQR 1;2.5) day vs. 1 (IQR 0;1) day 233 
for EDA and PCA group, respectively (P=0.213). 234 
Thirty-five out of 65 EDA patients and 19 of 57 PCA patients developed 235 
postoperative complications (P=0.029). The detailed grading of severity and a list of 236 
individual complications are provided as online appendix (A, B). 237 
Hospital stay was 7 (IQR 4.5;12) days for patients with EDA and 5 (IQR 4;8) days in 238 
the PCA group (P=0.434). Three patients from the EDA group were readmitted after 239 
discharge (PCA: 0; P=0.247). 240 
 241 
Perioperative fluid management, vasopressor requirements and perioperative pain 242 
Perioperative fluid management was similar between the groups. EDA and 243 
PCA patients received 1604±962ml vs. 1575±851ml balanced crystalloids (P=0.861) 244 
and 817±429ml vs. 664±294ml colloids (P=0.051). Weight gain on POD1 compared 245 
to preoperatively was 1.45±0.32kg in the EDA group and 2.28±0.56kg in the PCA 246 
group (P=0.191). Significantly more patients with EDA needed vasopressor treatment 247 
during surgery and until POD 1, while no single patient required vasopressors after 248 
POD 3 (Figure 2). Pain was overall well controlled by both modalities and no 249 
significant differences were noted at any time point (Figure 3). 250 
 251 
Subgroup analysis 252 
A tendency to more major complications was observed in the EDA group (15 253 
vs. 5, P=0.213). As major complications have a significant impact on primary and 254 
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secondary outcome measures, a post hoc analysis was performed excluding patients 255 
with major complications. Fifty EDA patients were compared with 52 PCA patients. 256 
Medical recovery and high dependency stay were significantly shorter in the PCA 257 
group (P=0.050 and P=0.010), respectively, while hospital stay was similar (Figure 258 
4).  The ERAS® protocol was modified during the study period and the first 26 259 
consecutive patients were not treated within the complete pathway as mentioned in 260 
the methods section. The second subgroup analysis included therefore only patients 261 
with full ERAS® pathway and having no major complication. Again, the PCA group 262 
had significantly shorter medical recovery (P=0.019) and stay in the high dependency 263 
unit (P<0.001) compared with patients having EDA (online appendix C). 264 
265 
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Discussion 266 
This present study shows that epidurals rather impede recovery after 267 
laparoscopic colorectal resections without delivering superior pain relief or other 268 
benefits. A major drawback identified was transitory hemodynamic instability 269 
requiring vasopressor treatment in a significant proportion of EDA patients. So the 270 
hypothesis was not verified and enhanced recovery pathways should not recommend 271 
the use of epidurals for laparoscopic colorectal resections. 272 
 273 
Main finding of the present study was a trend for longer medical recovery in 274 
EDA patients that became significant in the analyzed subgroups. One explanation 275 
might be the transitory hemodynamic instability due to sympathetic blockage in 276 
patients with EDA as confirmed by our reports and by others8, 31, 32. This also explains 277 
the observed longer stay in the high dependency unit. Overall length of stay was not 278 
significantly changed. Hospital stay relies on various factors, which may modify to a 279 
certain extent the effect of perioperative care and different analgesic regimens in 280 
particular24. Logistic and economic resources differ between countries and 281 
institutions and socio-cultural differences cannot be neglected; comparison of 282 
hospital stay can therefore be misleading. Medical recovery is the more specific 283 
endpoint that tends to occur about 2 days before discharge as shown by our group 284 
and by others25. Actually, only Levy et al. reported significantly shorter hospital stay 285 
in patients with PCA16, while several other randomized studies comparing EDA vs. 286 
PCA for laparoscopic colorectal resections did not find any difference9-11. Small 287 
patient samples however limit those trials. Levy reported further extremely short 288 
postoperative stays of 2.7 days only in patients with PCA16. Proven benefits of EDA 289 
for major and especially open procedures (e.g. superior pain relief, reduction of 290 
cardiopulmonary complications, faster bowel recovery)8 are probably minor and 291 
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irrelevant for minimal-invasive procedures with very short stays14, 16; this being said, 292 
minor drawbacks like pruritus and especially transitory hypotension become 293 
problematic and may increase stay at a high dependency unit and slow down 294 
recovery as shown in the present study and observed by others 8, 9, 16, 31, 32. 295 
Colon and rectal surgery differ considerably in terms of technique, surgical 296 
trauma and early outcomes. The most recent ERAS® recommendations were 297 
therefore issued separately for the two entities4, 5. While the available data from the 298 
present study and previous ones appears to be sufficient to abandon EDA for 299 
laparoscopic colon resections, evidence is insufficient to for rectal resections as the 300 
collectives in the respective randomized trials are too small9, 10, 16.  301 
 EDA failed in 12% of the patients in our study and was removed in 28% 302 
patients after anticipated POD 2. These “deviations” disfavor the EDA group on the 303 
one hand but reflect clinical realities on the other hand8, 33. Further, epidural 304 
analgesia can be performed at different thoracic levels, and combination and 305 
concentration of medications vary considerably. The results of our study can 306 
therefore not be uncritically generalized to other settings. However, the institutional 307 
technique applied in the present study and the reported success rates were in line 308 
with recent publications and might therefore still be of interest for many institutions 8, 309 
20, 33. Several interesting alternatives for perioperative pain management have been 310 
suggested meanwhile and favorable results have been reported in particular for 311 
laparoscopic transverse abdominus plane blocks, wound infiltration, systemic 312 
steroids and systemic lidocaine 17, 18. 313 
 314 
 Several limitations need to be addressed. Both groups were well matched by 315 
means of randomization. However, EDA patients experienced more overall and 316 
major complications than patients with PCA. These were mainly unrelated 317 
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complications entailing a potential bias disfavoring the EDA group. Therefore, 318 
patients with major complications were excluded in a post hoc subgroup analysis 319 
because of an obvious impact on outcome. Postoperative pain management is 320 
embedded in a global care scheme and the impact of EDA or other modalities on 321 
recovery, pain relief and length of stay needs to be interpreted in this context. As 322 
mentioned in the methods section, the enhanced recovery pathway was adapted 323 
during the study period. In order to avoid the bias of various perioperative care 324 
pathways and unbalanced major complications, a second subgroup analysis was 325 
performed with all consecutive patients within the full ERAS® pathway and without 326 
major complications. The interesting point was that both subgroup analyses 327 
confirmed the results of the main analysis according to the intention-to-treat principle, 328 
and resulted in significantly reduced times for medical recovery and high dependency 329 
stay in PCA patients. 330 
 331 
In conclusion, the present study suggests that epidurals decrease blood 332 
pressure in about one third of patients who therefore require transitory hemodynamic 333 
support and a prolonged stay in a high dependency unit. Thus, EDA impedes 334 
recovery after laparoscopic colorectal resections without providing superior pain relief 335 
or reduced complications when compared with morphine-based PCA. Hospital stay 336 
remains unchanged. EDA should therefore not be a mandatory item of ERAS® 337 
pathways in laparoscopic surgery. The most recent ERAS®  recommendations 338 
already considered the new evidence4, 5, and modern alternatives to morphine-based 339 
regimens deserve future investigations. 340 
341 
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Table 1 Demographic and surgical details comparing patients with epidural vs. 
patient-controlled analgesia. 
 
 EDA 
N=65 
PCA 
N=57 
P 
Age (years) 63.1±15.1 61.2±17.8 0.529 
Male gender (%) 37 (57%) 34 (60%) 0.854 
BMI (kg/m2) 25.9±5.1 25.5±4.2 0.980 
ASA I/II/III 6/49/10 7/41/9 0.853 
Charlson 3.2±3.3 3.2±3.8 0.822 
Malignant/benign disease 43/22 37/20 0.518 
Type of surgery 
 Left/sigmoid colectomy 
 Right/ileocecal resection 
 Rectum/(sub)total 
 Other 
 
30 (46%) 
18 (28%) 
10 (15%) 
7 (11%) 
 
27 (47%) 
13 (23%) 
11 (19%) 
6 (11%) 
0.904 
Conversion, No. of (%) 12 (19%) 8 (14%) 0.625 
OR time (min) 239±107 235±104 0.832 
Estimated blood loss (ml) 232±217 169 ±152 0.095 
 
Mean values ± standard deviation or no. of patients (%). 
EDA – epidural analgesia, PCA – patient-controlled opioid-based analgesia, BMI – 
body mass index, ASA - American Society of Anesthetists, OR time – operation room 
time. 
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Online appendix A Postoperative complications by severity. 
 
 EDA 
N=65 
PCA 
N=57 
P 
No. of patients (%) with  
Any complication 
 
35 (54%) 
 
 
19 (33%) 
 
0.029 
 Grade I 4 4  
 Grade II 16 10  
 Grade III a/b 2 / 9 0 / 2  
 Grade IV a/b 0 / 2 3 / 0  
 Grade V (mortality) 2 0  
Major complications (≥III) 15 (23%) 5 (9%) 0.213 
Reoperation 9 (14%) 4 (7%) 0.254 
 
Postoperative complications were graded by severity according to the Dindo-Clavien 
classification 26. Complications grade III-V were summarized as major morbidity. 
EDA – epidural analgesia, PCA – patient-controlled opioid-based analgesia. 
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Online appendix B List of surgical and medical complications. 
 
 EDA 
N=65 
PCA 
N=57 
Surgical 21 10 
 Anastomotic leak 4 1 
 Bleeding 0 1 
 Surgical site infection 2 0 
 Ileus 13 5 
 Other 2 3 
Medical 14 9 
 Pulmonary 1 1 
 Cardiac 1 0 
 Renal 3 2 
 Urinary retention 11 7 
 Other 3 5 
 
The most frequent postoperative complications are summarized for patients with 
epidural analgesia (EDA) and patient-controlled opioid-based analgesia (PCA). 
 24 
Figure 1 Study flow chart. 
 
 
 
CONSORT diagram. Randomized controlled trial comparing epidural analgesia (EDA) 
versus patient-controlled opioid-based analgesia (PCA) for laparoscopic colorectal 
surgery. 
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Figure 2 Perioperative vasopressor requirements. 
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Percentage of patients in the EDA (white circles) and PCA group (black rectangles), 
respectively, requiring vasopressor treatment during and after laparoscopic colorectal 
surgery. 
EDA – epidural analgesia, PCA – patient-controlled opioid-based analgesia. 
* indicates statistical significance (P<0.05). 
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Figure 3 Perioperative pain scores. 
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Pain was assessed by use of a visual analogue scale (VAS) from 0-10 before surgery, 
the evening after surgery and twice daily thereafter until postoperative day (POD) 4 for 
patients with EDA (white circles) and PCA (black rectangles), respectively. 
EDA – epidural analgesia, PCA – patient-controlled opioid-based analgesia. 
* indicates statistical significance (P<0.05). 
Data expressed as mean±SD. 
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Figure 4 Subgroup analysis excluding patients with major complications.  
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A Post hoc subgroup analysis included all patients without major complications: 50 
EDA patients vs. 52 PCA patients were compared with regards to medical recovery, 
and length of stay in a high dependency unit and in hospital, respectively. 
EDA – epidural analgesia, PCA – patient-controlled opioid-based analgesia. 
* indicates statistical significance (P<0.05). 
Data expressed as mean±SD.  
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Online appendix C  Subgroup analysis: patients with full ERAS® pathway and  
    having no major complications. 
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Patients within the full ERAS® pathway and without major complications (40 EDA vs. 
40 PCA) were compared concerning medical recovery, high dependency and hospital 
stay. 
EDA – epidural analgesia, PCA – patient-controlled opioid-based analgesia. 
* indicates statistical significance (P<0.05). 
Data expressed as mean±SD. 
